Survivorship Care Plans and Telehealth Education for the Improvement of Access to Cancer Survivorship, the IMPACT Study
This trial studies how well self-generated survivorship care plans and telehealth education works in improving knowledge and self-efficacy in cancer survivors living in rural areas. Patients living in rural areas often face barriers to survivorship care and report unmet needs. A survivorship care plan created by the patient (self-generated) may help them to better transition from oncology to primary care and improve communication between care teams in order to meet these needs and create better health outcomes. Telehealth is a way of delivering health care services from a distance, including patient education. Combining a self-generated survivorship care plan with telehealth education may help to improve knowledge and self-efficacy in cancer survivors.
Ask AI to explain this studyKey things to know
This describes the study’s primary purpose.
Plus 2 other study approaches.
These are broad labels—not an eligibility decision.
Checked against the public recordLast updated Apr 8, 2026 · Source: ClinicalTrials.gov
Ask the study team to confirm whether enrollment is open.
Interventional
Locations may change over time.
Study sponsor
What this study is about
- Purpose
- Supportive Care
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- Fred Hutchinson Cancer Center
- Interventions being studied
- Other: Survivorship Care Plan; Other: Educational Intervention; Other: Questionnaire Administration; Other: Supportive Care
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.
- Cancer survivors who have completed curative therapy within the past 5 years (may still currently be on long-term/targeted non-cytotoxic agent maintenance therapy, e.g., tamoxifen or aromatase inhibitors for breast cancer survivors; androgen deprivation therapy for prostate cancer survivors)
- History of either adult-onset (age \>= 18) lymphoma, breast, colorectal, lung, or prostate cancer
- Able to perform all study requirements, including responding to questionnaires
- Willing to be randomized
- Capable of providing informed consent
- Consent to release oncology and primary care medical records
- English or Spanish speakers
- PRIMARY CARE PROVIDERS: PCPs responsible for delivering primary care to IMPACT study participants will be contacted about participating in the study after participant enrollment into the study.
- ONCOLOGY STAFF: Oncology Staff (Oncologists, Nurse Practitioners, Physician's assistants) will be recruited from sites involved in the IMPACT study
- CLINIC ADMINISTRATORS: Clinic administrators will be recruited from sites involved in the IMPACT study
- Currently on palliative or hospice care, or considering transferring to such care within the next 3 months
- Lacks telephone access
- Lacks mailing address or ability to receive study materials electronically
- Currently being followed in a pediatric clinical setting (either for primary care or for cancer care)
- History of having had \> 1 cancer type diagnosed and treated (exception is for skin cancers treated with surgical excision alone; also, individuals who only have had relapse of their initial cancer remain eligible so long as they have completed curative therapy and meet all other eligibility criteria)
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Fred Hutch/University of Washington Cancer ConsortiumSeattle, Washington
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Apr 8, 2026. Always confirm current availability with the study team.